A research team from the Korea Advanced Institute of Science and Technology has developed an AI model to predict adverse reactions between oral anti-COVID-19 medication and prescription drugs.
Researchers from KAIST's Department of Biochemical Engineering made a new version of the DeepDDI AI-based drug interaction prediction model to check how ritonavir and nirmatrelvir, two components of...
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology.
Pfizer will leverage Tempus' library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus' AI-driven companion diagnostic offerings...
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, entered into a multiyear partnership with Pfizer to develop an AI-based tool for the early detection of cardiac amyloidosis.
Under the agreement, Anumana will research and pursue FDA De Novo classification for an algorithm that could find signals within electrocardiograms (ECGs) that hint at the condition. The...
Canadian health tech company PointClickCare announced a strategic collaboration with Pfizer to share its real-world data on seniors.
The cloud-based software company focused on elder care covers the long-term and post-acute care market. PointClickCare will provide Pfizer with real-world data insights that specifically represent older adults, especially those in long-term care facilities, to help...
Pfizer completes ResApp purchase for over $115 million
Biopharmaceutical giant Pfizer has finalised its acquisition of ASX-listed digital health startup ResApp for A$179 million ($116 million), according to the University of Queensland.
Brisbane-based ResApp has developed a mobile app that analyses cough sounds and diagnoses respiratory diseases, including asthma, pneumonia, bronchiolitis, croup...
Digital therapeutics firm, Sidekick Health has joined forces with pharma giant Pfizer to launch an integrated digital therapeutics solution for Atopic Dermatitis (AD).
The solution will be rolled-out in the UK first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year.
This marks the next phase of a growing collaboration between Sidekick and Pfizer to...
Biopharmaceutical giant Pfizer has offered AU$100 million (US$74.43 million) to acquire Australian company ResApp, which has developed a mobile app to diagnose COVID-19 by the sound of a person's cough.
In its announcement of the proposed acquisition to the Australian Stock Exchange, ResApp said Pfizer will acquire 100 per cent of the company's shares following an anticipated positive shareholder...
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.
However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
Pharma giant Pfizer is setting its sights on the digital therapeutics space, inking a new strategic commercial partnership with Swedish startup Alex Therapeutics.
The joint effort will tap into Alex Therapeutics AI-based platform that integrates both cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI in order to personalize care. Initially the pair will focus...
Digital mental health platform ThoughtFull and pharmaceutical firm Pfizer Singapore have signed an exclusive partnership to bring more access to biopsychosocial care to people in Singapore.
The collaboration aims to counter the stigma around mental health and bridge the gap in treatment.
Under this partnership, ThoughtFull will be providing free three-month access to counsellor or psychologist...
_9.JPG?itok=yNwUpNTb)
_10.JPG?itok=Coh2mBoC)
